CFC
VIVO

Cincinnati Financial Corp’s Meridian Bioscience Inc VIVO Stock Holding History

Cincinnati Financial Corp’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-230,000
Closed -$5.01M – 47
2014
Q1 		$5.01M Sell
230,000
-550,000
-71% -$12.6M 0.36% 43
2013
Q4 		$20.7M Hold
780,000
– – 1.52% 24
2013
Q3 		$18.4M Hold
780,000
– – 1.47% 25
2013
Q2 		$16.8M Buy
+780,000
New +$16.8M 1.4% 26

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cincinnati Financial Corp's VIVO Position: Q2 2014 in Review

Cincinnati Financial Corp sold out of Meridian Bioscience Inc (VIVO) in Q2 2014, closing a stake of 230,000 shares — an estimated $5.01M sold.

Cincinnati Financial Corp first reported a position in VIVO in Q2 2013 and held it in 4 quarters. The position peaked at $20.7M in Q4 2013. 161 funds tracked by Wall St. Rank hold VIVO as of Q2 2014.

  • Cincinnati Financial Corp reported no remaining Meridian Bioscience Inc position as of Q2 2014 after selling out during the quarter.
  • Cincinnati Financial Corp sold 230,000 Meridian Bioscience Inc shares in Q2 2014, an estimated $5.01M.
  • Cincinnati Financial Corp first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 4 quarters.
  • Cincinnati Financial Corp's Meridian Bioscience Inc position peaked at $20.7M in Q4 2013.
  • 161 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2014.

Based on Cincinnati Financial Corp's 13F filing for Q2 2014, filed 8 Aug 2014.